Avastin and Malignant Gliomas

Book Series: Controversies in Neuro-Oncology

Volume 1

by

Thomas C. Chen, Marc Chamberlain

DOI: 10.2174/97816080513281100101
eISBN: 978-1-60805-132-8, 2010
ISBN: 978-1-60805-519-7
ISSN: 2210-5565 (Print)



Indexed in: Chemical Abstracts, EBSCO, Ulrich's Periodicals Directory.

Neuro-oncology is an embryonic field of cancer research with a number of clinical trials in progress. However, the prognosis on neuro-...[view complete introduction]
US $
Buy Personal Book
79
Order Library Book
316
Order Printed Copy
*119
Order PDF + Printed Copy (Special Offer)
*158

*(Excluding Mailing and Handling)

🔒Secure Checkout Personal information is secured with SSL technology
Download Flyer

Bevacizumab and Malignant Glioma: Is there a Role for Upfront Therapy?

- Pp. 40-45 (6)

Jing Wu and Mark R. Gilbert

Abstract

<p>Angiogenesis, largely driven by vascular endothelial growth factor (VEGF) is essential to the growth of glioblastoma (GBM). Furthermore, a mesenchymal gene signature related to vascular proliferation has been identified in a subset of poor prognosis GBM patients suggesting that a proangiogenic phenotype negatively influences survival. Therefore, disruption of the angiogenic cascade is a logical therapeutic target. Recently, antiangiogenic therapy using bevacizumab, a VEGF targeting antibody, has shown promise against recurrent GBMs. A Phase III double blind placebo-controlled trial, RTOG 0825 was recently launched to compare conventional concurrent chemoradiation and adjuvant temozolomide plus bevacizumab versus treatment without bevacizumab in patients with newly diagnosed glioblastoma. MGMT methylation status and molecular profile are incorporated into the stratification design. This will not only balance the two treatment arms for these prognostic factors, but also may lead to prospective determination of optimal, individualized therapy based on tumor specific molecular profiles.</p>

Purchase Chapter  Book Details

Advertisement

Special New Year Discount

Webmaster Contact: info@benthamscience.net Copyright © 2019 Bentham Science